首页> 外文期刊>Pediatric Pulmonology >ABCA3 Mutations Led to Pulmonary Fibrosis and Emphysema With Pulmonary Hypertension in an 8-Year-Old Girl
【24h】

ABCA3 Mutations Led to Pulmonary Fibrosis and Emphysema With Pulmonary Hypertension in an 8-Year-Old Girl

机译:ABCA3突变导致8岁女孩肺纤维化和肺气肿伴肺动脉高压

获取原文
获取原文并翻译 | 示例
           

摘要

ABCA3 is highly expressed in alveolar epithelial type 2 cells and is associated with surfactant homeostasis. Patients with ABCA3 mutations develop various respiratory complications, such as fatal respiratory distress syndrome or interstitial lung disease. We describe a patient with pulmonary fibrosis and emphysema with pulmonary hypertension, associated with compound heterozygous mutations of the ABCA3 gene. This is the first report showing that mutations in the ABCA3 gene lead to pulmonary fibrosis and emphysema, including combined pulmonary fibrosis and emphysema, in childhood. Treatment with prostacyclin analogue, warfarin, and inhaled oxygen was effective to improve patient's hemodynamic condition as well as pulmonary fibrosis and emphysema. (C) 2016 Wiley Periodicals, Inc.
机译:ABCA3在2型肺泡上皮细胞中高度表达,并与表面活性剂稳态相关。具有ABCA3突变的患者会出现各种呼吸系统并发症,例如致命的呼吸窘迫综合征或间质性肺疾病。我们描述了患有肺纤维化和肺气肿并伴有肺动脉高压的患者,其与ABCA3基因的复合杂合突变有关。这是第一个报告,表明ABCA3基因的突变会导致儿童时期的肺纤维化和肺气肿,包括合并的肺纤维化和肺气肿。用前列环素类似物,华法令和吸入氧气进行治疗可有效改善患者的血流动力学状况以及肺纤维化和肺气肿。 (C)2016威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号